1. Responses to analogues of growth hormone-releasing hormone in normal subjects, and in growth-hormone deficient children and young adults;Grossman;Clinical Endocrinology,1984
2. An extremely sensitive in vitro model for elucidating structure-activity relationships of growth hormone-releasing factor analogs;Heiman;Endocrinology,1985
3. Pharmacokinetic evaluation of superactive analogues of growth hormone-releasing factor (1-29)-amide;Rafferty;Peptides,1988
4. Incorporation of D-Ala2 in growth hormone-releasing hormone-(1-29)-NH2 increases the half-life and decreases metabolic clearance in normal men;Soule;The Journal of Clinical Endocrinology and Metabolism,1994
5. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group;Thorner;The Journal of Clinical Endocrinology and Metabolism,1996